AIRS
AirSculpt Technologies, Inc.NASDAQHealthcare$3.17+16.12%ClosedMarket Cap: $197.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.18
P/S
1.30
EV/EBITDA
48.16
DCF Value
$-0.11
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.7%
Operating Margin
-7.6%
Net Margin
-7.7%
ROE
-13.8%
ROA
-17.0%
ROIC
-5.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $33.4M | 200.8% | $-1.0M | $1.3M | $0.02 | — |
| FY 2025 | $151.8M | 0.0% | $-11.6M | $-11.7M | $-0.19 | — |
| Q3 2025 | $35.0M | 65.5% | $-9.8M | $-9.5M | $-0.15 | — |
| Q2 2025 | $44.0M | 64.8% | $786.0K | $-591.0K | $-0.01 | — |
| Q1 2025 | $39.4M | 64.1% | $-1.6M | $-2.8M | $-0.05 | — |
| Q4 2024 | $39.2M | 61.6% | $-4.1M | $-5.0M | $-0.09 | — |
| FY 2024 | $180.3M | 60.4% | $-1.8M | $-8.3M | $-0.14 | — |
| Q3 2024 | $42.5M | 62.5% | $-3.7M | $-6.0M | $-0.10 | — |
| Q2 2024 | $51.0M | 66.2% | $-5.0M | $-3.2M | $-0.06 | — |
| Q1 2024 | $47.6M | 56.2% | $11.0M | $6.0M | $0.10 | — |
| Q4 2023 | $47.6M | 62.5% | $1.4M | $-4.6M | $-0.08 | — |
| FY 2023 | $195.9M | 62.2% | $9.5M | $-4.5M | $-0.08 | — |